Serum Osteocalcin Levels in Diabetes Mellitus: Analysis of the Type of Diabetes and Microvascular Complications

Overview

Journal Diabetologia

Specialty Endocrinology

Date 1988 Dec 1

PMID 3266486

Citations 39

Authors

P Pietschmann

G Schernthaner

W Woloszczuk

Affiliations

Soon will be listed here.

Abstract

Recent studies indicate that serum levels of osteocalcin, a 49-aminoacid bone matrix protein, are a biochemical marker of bone formation. In order to study bone metabolism in diabetes mellitus, in 28 patients with Type 1 (insulin-dependent) diabetes mellitus, in 38 patients with Type 2 (non-insulin-dependent) diabetes mellitus and two control groups, matched for Type 1 and Type 2 diabetic patients, respectively, serum levels of osteocalcin, parathyroid hormone and 25 hydroxy vitamin D were measured by radioimmunoassay. Whereas in Type 1 diabetic patients and control subjects serum levels of osteocalcin and 25 hydroxy vitamin D were not statistically different, serum osteocalcin and 25 hydroxy vitamin D levels were significantly decreased in Type 2 diabetic patients when compared with corresponding control subjects (p less than 0.03 and p less than 0.001, respectively). Independent of the type of diabetes, serum parathyroid hormone levels were comparable in diabetic patients and matched control subjects. Serum osteocalcin levels were significantly lower in Type 1 diabetic patients with retinopathy and/or proteinuria than in Type 1 diabetic patients without microangiopathy (p less than 0.05). Whereas serum parathyroid hormone levels in Type 2 diabetic patients with retinopathy and/or proteinuria were significantly increased (p less than 0.02), 25 hydroxy vitamin D levels were decreased (p less than 0.02) when compared with Type 2 diabetic patients without microangiopathy. Our data give evidence of a vitamin D deficiency and a decreased bone formation in patients with Type 2 diabetes mellitus. In Type 1 diabetes mellitus bone formation as reflected by serum osteocalcin levels is influenced by the presence or absence of microangiopathic complications.

Citing Articles

Investigating the Association between Diabetic Neuropathy and Vitamin D in Emirati Patients with Type 2 Diabetes Mellitus.

Al Ali T, Ashfaq A, Sharif-Askari N, Abusnana S, Mussa B Cells. 2023; 12(1).

PMID: 36611991 PMC: 9818413. DOI: 10.3390/cells12010198.

Impact of diabetes status and related factors on COVID-19-associated hospitalization: A nationwide retrospective cohort study of 116,370 adults with SARS-CoV-2 infection.

Tallon E, Ebekozien O, Sanchez J, Staggs V, Ferro D, McDonough R Diabetes Res Clin Pract. 2022; 194:110156.

PMID: 36400172 PMC: 9663407. DOI: 10.1016/j.diabres.2022.110156.

The Association between Vitamin D Hypovitaminosis and Cardiovascular Disease Risk in Saudi Diabetic Patients Type II.

ALrefai A, Elsalamony E, Fatani S, Kasemy Z, Fatani A, Mohamed Kamel H Biochem Res Int. 2022; 2022:6097864.

PMID: 36193546 PMC: 9525733. DOI: 10.1155/2022/6097864.

Meta-analysis of Diabetes Mellitus-Associated Differences in Bone Structure Assessed by High-Resolution Peripheral Quantitative Computed Tomography.

Walle M, Whittier D, Frost M, Muller R, Collins C Curr Osteoporos Rep. 2022; 20(6):398-409.

PMID: 36190648 PMC: 9718715. DOI: 10.1007/s11914-022-00755-6.

Hypovitaminosis D and the endocrine phenotype of COVID-19.

Giustina A Endocrine. 2021; 72(1):1-11.

PMID: 33738708 PMC: 7972333. DOI: 10.1007/s12020-021-02671-8.

References

Nyomba B, Bouillon R, Bidingija M, Kandjingu K, DE MOOR P . Vitamin D metabolites and their binding protein in adult diabetic patients. Diabetes. 1986; 35(8):911-5. DOI: 10.2337/diab.35.8.911. View

Price P, Williamson M, Lothringer J . Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem. 1981; 256(24):12760-6. View

De Leeuw I, Abs R . Bone mass and bone density in maturity-type diabetics measured by the 125I photon-absorption technique. Diabetes. 1977; 26(12):1130-5. DOI: 10.2337/diab.26.12.1130. View

Hahn T, DOWNING S, Phang J . Insulin effect on amino acid transport in bone: dependence on protein synthesis and Na+. Am J Physiol. 1971; 220(6):1717-23. DOI: 10.1152/ajplegacy.1971.220.6.1717. View

MEEMA H, MEEMA S . The relationship of diabetes mellitus and body weight to osteoporosis in elderly females. Can Med Assoc J. 1967; 96(3):132-9. PMC: 1935927. View

Santiago J, McALISTER W, Ratzan S, Bussman Y, Haymond M, Shackelford G . Decreased cortical thickness & osteopenia in children with diabetes mellitus. J Clin Endocrinol Metab. 1977; 45(4):845-8. DOI: 10.1210/jcem-45-4-845. View

Wiske P, Wentworth S, NORTON Jr J, Epstein S, JOHNSTON Jr C . Evaluation of bone mass and growth in young diabetics. Metabolism. 1982; 31(8):848-54. DOI: 10.1016/0026-0495(82)90086-5. View

Shore R, Chesney R, Mazess R, Rose P, Bargman G . Osteopenia in juvenile diabetes. Calcif Tissue Int. 1981; 33(5):455-7. DOI: 10.1007/BF02409473. View

Tsai K, Wahner H, Offord K, Melton 3rd L, Kumar R, Riggs B . Effect of aging on vitamin D stores and bone density in women. Calcif Tissue Int. 1987; 40(5):241-3. DOI: 10.1007/BF02555255. View

10.

Auwerx J, Dequeker J, Bouillon R, Geusens P, Nijs J . Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus. Diabetes. 1988; 37(1):8-12. DOI: 10.2337/diab.37.1.8. View

11.

Heath 3rd H, Lambert P, Service F, Arnaud S . Calcium homeostasis in diabetes mellitus. J Clin Endocrinol Metab. 1979; 49(3):462-6. DOI: 10.1210/jcem-49-3-462. View

12.

Levin M, Boisseau V, Avioli L . Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med. 1976; 294(5):241-5. DOI: 10.1056/NEJM197601292940502. View

13.

FORGACS S, Rosinger A, Vertes L . Diabetes mellitus and osteoporosis. Endokrinologie. 1976; 67(3):343-50. View

14.

McNair P, Moller-Petersen J, Madsbad S . Serum calcium fractions in diabetes mellitus. Clin Chem. 1982; 28(10):2073-6. View

15.

Storm T, Sorensen O, Lund B, Christiansen J, Andersen A, Lumholtz I . Vitamin D metabolism in insulin-dependent diabetes mellitus. Metab Bone Dis Relat Res. 1983; 5(3):107-10. DOI: 10.1016/0221-8747(83)90010-3. View

16.

McNair P, Madsbad S, Christiansen C, Faber O, TRANSBOL I, Binder C . Osteopenia in insulin treated diabetes mellitus. Its relation to age at onset, sex and duration of disease. Diabetologia. 1978; 15(2):87-90. DOI: 10.1007/BF00422250. View

17.

Bartl R, Moser W, Burkhardt R, Sandel P, Kamke W, MAHR G . [Diabetic osteomyelopathy: histobioptic data of bone and bone marrow in diabetes mellitus (author's transl)]. Klin Wochenschr. 1978; 56(15):743-54. DOI: 10.1007/BF01476763. View

18.

Pietschmann P, Woloszczuk W, Panzer S, Kyrle P, Smolen J . Decreased serum osteocalcin levels in phenprocoumon-treated patients. J Clin Endocrinol Metab. 1988; 66(5):1071-4. DOI: 10.1210/jcem-66-5-1071. View

19.

Brown J, Delmas P, Malaval L, Edouard C, CHAPUY M, Meunier P . Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet. 1984; 1(8386):1091-3. DOI: 10.1016/s0140-6736(84)92506-6. View

20.

Price P, Parthemore J, Deftos L . New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. J Clin Invest. 1980; 66(5):878-83. PMC: 371521. DOI: 10.1172/JCI109954. View